Integrum receives ISO 13485 certification confirming its robust quality management system

Report this content

Mölndal, Sweden, October 17th, 2022 – Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announced that the company has received ISO 13485 certification for medical devices from BSI Group the Netherlands B.V. The certification is an external validation of Integrum’s long-term efforts to secure a high level of internal quality control.

ISO 13845 is an international standard designed to be used by organizations involved in the design, production, installation and servicing of medical devices and related services. The ISO 13485 certificate confirms that Integrum’s quality management system meets the most current regulatory requirements for the medical device industry.

“Having a best-in-class quality management system is fundamental in our ongoing international expansion. This certificate is yet another proof that Integrum has well-established processes in place to meet regulatory requirements in all parts of the world,” comments Rickard Brånemark, CEO of Integrum.

For more information please contact:

Rickard Brånemark, CEO. +46 (0) 70 846 10 61, E-mail:

Dennis Baecklund, CFO. +46 (0) 72 556 68 69, E-mail:

Certified Adviser

Erik Penser Bank is Certified Adviser and can be reached at +46 (0) 8-463 8000.

Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a US subsidiary in San Francisco, CA. Since 1990, osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations enjoy a dramatically improved quality of life. Thorough surgical experience gained over more than three decades, from more than 500 surgeries, in 14 countries, has led to the development of Integrum’s system for bone-anchored prostheses – a vastly superior alternative to the traditionally used socket prosthesis